StockData
10x Genomics, Inc. logo

10x Genomics, Inc. (TXG) stock

TXGNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 9/30106% above fair value
$56.30+1.31 (+2.38%)

Close on Nov 17, 2026Market cap $7.34BP/E –Yield –

10x Genomics r&d expenses

Research and development expenses are spending on new products and technology.

10x Genomics's R&D Expenses for the twelve months ending Sep 30, 2026 was $222.54M, down 10.9% year over year. For fiscal 2025 it was $238.63M, down 9.8% from the year before. The highest annual figure on record is $270.33M in fiscal 2023.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$238.63M-9.8%
FY2024Dec 31, 2024$264.70M-2.1%
FY2023Dec 31, 2023$270.33M+1.8%
FY2022Dec 31, 2022$265.67M+25.5%
FY2021Dec 31, 2021$211.75M+71.6%
FY2020Dec 31, 2020$123.38M+48.5%
FY2019Dec 31, 2019$83.10M+74.8%
FY2018Dec 31, 2018$47.54M+47.8%
FY2017Dec 31, 2017$32.16M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$52.93M-7.5%
Q2 FY2026Jun 30, 2026$56.79M-7.2%
Q1 FY2026Mar 31, 2026$56.85M-11.5%
Q4 FY2025Dec 31, 2025$55.97M-16.4%
Q3 FY2025Sep 30, 2025$57.19M-13.6%
Q2 FY2025Jun 30, 2025$61.22M-2.7%
Q1 FY2025Mar 31, 2025$64.25M-6.4%
Q4 FY2024Dec 31, 2024$66.97M+2.6%
Q3 FY2024Sep 30, 2024$66.17M-0.5%
Q2 FY2024Jun 30, 2024$62.92M-12.0%
Q1 FY2024Mar 31, 2024$68.64M+2.3%
Q4 FY2023Dec 31, 2023$65.27M+2.6%
Q3 FY2023Sep 30, 2023$66.51M-1.2%
Q2 FY2023Jun 30, 2023$71.46M+1.1%
Q1 FY2023Mar 31, 2023$67.10M+4.7%
Q4 FY2022Dec 31, 2022$63.61M+2.8%
Q3 FY2022Sep 30, 2022$67.29M+23.3%
Q2 FY2022Jun 30, 2022$70.69M+32.4%
Q1 FY2022Mar 31, 2022$64.08M+53.0%
Q4 FY2021Dec 31, 2021$61.89M+55.9%
Q3 FY2021Sep 30, 2021$54.58M+81.1%
Q2 FY2021Jun 30, 2021$53.40M+93.9%
Q1 FY2021Mar 31, 2021$41.88M+61.1%
Q4 FY2020Dec 31, 2020$39.71M+42.4%
Q3 FY2020Sep 30, 2020$30.14M+35.7%
Q2 FY2020Jun 30, 2020$27.54M+52.7%
Q1 FY2020Mar 31, 2020$25.99M+73.7%
Q4 FY2019Dec 31, 2019$27.89M+113.2%
Q3 FY2019Sep 30, 2019$22.21M+100.4%
Q2 FY2019Jun 30, 2019$18.03M–
Q1 FY2019Mar 31, 2019$14.97M–
Q4 FY2018Dec 31, 2018$13.08M–
Q3 FY2018Sep 30, 2018$11.09M–

More 10x Genomics figures

See a number that looks wrong?